GSK gets Jesduvroq FDA approval for anaemia of chronic kidney disease

Raghuram Kadari- February 4, 2023 0

GSK has secured the approval of the US Food and Drug Administration (FDA) for the company’s Jesduvroq (daprodustat) for anaemia of chronic kidney disease (CKD) ... Read More